Concentra Biosciences LLC, controlled by San Diego's Tang Capital Partners LP, made an unsolicited offer at $3 per share plus ...

Here's how an activist investor is threatening a Peninsula drug maker's merger plans. And the drama introduces a potential ...

As part of an agreement announced two weeks ago, eye-disease-focused Acelyrin was due to be absorbed into immune-mediated ...

Acelyrin earlier this month agreed to an all-stock merger with fellow immune player Alumis, with their combined cash tiding ...

Shares of Acelyrin climbed after the company said it has received an unsolicited indication of interest from Concentra Biosciences for an acquisition at $3 a share. The stock was up 14% at $2.48 in ...

Select Medical Holdings Corporation (NYSE: SEM) Q4 2024 Earnings Call Transcript February 21, 2025 ...

Founder; Select Medical Holdings Corp Martin Jackson; Senior Executive Vice President of Strategic Finance and Operations; Select Medical Holdings Corp Good morning and thank you for joining us today ...

Acelyrin (SLRN) “confirmed receipt of an unsolicited indication of interest from Concentra Biosciences, LLC, of which Tang Capital Partners, LP ...

We recently published an article titled Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a ...

Select Medical (SEM) has disclosed a new risk, in the Litigation & Legal Liabilities category. Select Medical may face significant business risks ...